COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series
- PMID: 33569857
- PMCID: PMC7986084
- DOI: 10.1111/myc.13254
COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series
Abstract
Background: COVID-19-associated pulmonary aspergillosis (CAPA) has emerged as an invasive fungal disease, often affecting previously immunocompetent, mechanically ventilated, intensive care unit (ICU) patients. Incidence rates of 3.8%-33.3% have been reported depending on the geographic area, with high (47%) mortality.
Objectives: Here, we describe a single-centre prospective case series with CAPA cases from both the first (March-May, n = 5/33) and second (mid-September through mid-December, n = 8/33) COVID-19 wave at a 500-bed teaching hospital in the Netherlands.
Patients/methods: In the first COVID-19 wave, a total of 265 SARS-CoV-2 PCR-positive patients were admitted to our hospital of whom 33 needed intubation and mechanical ventilation. In the second wave, 508 SARS-CoV-2 PCR-positive patients were admitted of whom 33 needed mechanical ventilation. Data were prospectively collected.
Results: We found a significant decrease in COVID-19 patients needing mechanical ventilation in the ICU in the second wave (p < .01). From these patients, however, a higher percentage were diagnosed with CAPA (24.2% vs 15.2%), although not significant (p = .36). All CAPA patients encountered in the second wave received dexamethasone. Mortality between both groups was similarly high (40%-50%). Moreover, we found environmental TR34 /L98H azole-resistant Aspergillus fumigatus isolates in two separate patients.
Conclusions: In this series, 19.7% (n = 13/66) of mechanically ventilated SARS-CoV-2 patients were diagnosed with CAPA. In addition, we found a significant reduction in COVID-19 patients needing mechanical ventilation on the ICU in the second wave. Numbers are too small to determine whether there is a true difference in CAPA incidence in mechanically ventilated patients between the two waves, and whether it could be attributed to dexamethasone SARS-CoV-2 therapy.
Keywords: Aspergillus fumigatus; CAPA; ICU; TR34L98H; dexamethasone; pulmonary aspergillosis.
© 2021 The Authors. Mycoses published by Wiley-VCH GmbH.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.Lancet Respir Med. 2022 Feb;10(2):180-190. doi: 10.1016/S2213-2600(21)00442-2. Epub 2021 Nov 26. Lancet Respir Med. 2022. PMID: 34843666 Free PMC article.
-
A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.Mycoses. 2022 Jul;65(7):724-732. doi: 10.1111/myc.13466. Epub 2022 May 25. Mycoses. 2022. PMID: 35531631 Free PMC article.
-
COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.Microbiol Spectr. 2021 Oct 31;9(2):e0113821. doi: 10.1128/Spectrum.01138-21. Epub 2021 Oct 20. Microbiol Spectr. 2021. PMID: 34668768 Free PMC article.
-
Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.Mycoses. 2021 Feb;64(2):132-143. doi: 10.1111/myc.13213. Epub 2020 Nov 29. Mycoses. 2021. PMID: 33210776 Free PMC article. Review.
-
COVID-19-associated pulmonary aspergillosis: an underdiagnosed or overtreated infection?Curr Opin Crit Care. 2022 Oct 1;28(5):470-479. doi: 10.1097/MCC.0000000000000977. Epub 2022 Aug 11. Curr Opin Crit Care. 2022. PMID: 35950729 Free PMC article. Review.
Cited by
-
Pharmacokinetic Study of Intranasal Dexamethasone and Methylprednisolone Compared with Intravenous Administration: Two Open-Label, Single-Dose, Two-Period, Two-Sequence, Cross-Over Study in Healthy Volunteers.Pharmaceutics. 2022 Dec 28;15(1):105. doi: 10.3390/pharmaceutics15010105. Pharmaceutics. 2022. PMID: 36678735 Free PMC article.
-
Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum.J Clin Med. 2022 Apr 4;11(7):2017. doi: 10.3390/jcm11072017. J Clin Med. 2022. PMID: 35407625 Free PMC article. Review.
-
COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses.Microbiol Spectr. 2023 Mar 22;11(2):e0512822. doi: 10.1128/spectrum.05128-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36946762 Free PMC article.
-
A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave.Mycopathologia. 2023 Aug;188(4):335-344. doi: 10.1007/s11046-023-00750-0. Epub 2023 May 31. Mycopathologia. 2023. PMID: 37256502 Free PMC article.
-
Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients.J Fungi (Basel). 2022 Apr 17;8(4):415. doi: 10.3390/jof8040415. J Fungi (Basel). 2022. PMID: 35448646 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous